71045 CPT® code: payer coverage and prior authorization71045 appears in 18 coverage policies from Aetna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Abatacept (Orencia) (0720) | listed, no stance (range 71045-71048) | Jul 1, 2026 | payer document |
| Aetna | Adalimumab (0655) | listed, no stance (range 71045-71048) | Jul 13, 2026 | payer document |
| Aetna | Canakinumab (Ilaris) (0881) | listed, no stance | Aug 3, 2026 | payer document |
| Aetna | Certolizumab Pegol (Cimzia) (0761) | listed, no stance (range 71045-71048) | Jul 1, 2026 | payer document |
| Aetna | Etanercept (0315) CD11c expression and DNA methylation as biomarkers of etanercept response | listed, no stance (range 71045-71048) | Jul 8, 2026 | payer document |
| Aetna | Golimumab (Simponi and Simponi Aria) (0790) | listed, no stance (range 71045-71048) | Jul 31, 2026 | payer document |
| Aetna | Guselkumab (Tremfya) (1011) | listed, no stance (range 71045-71048) | Jun 29, 2026 | payer document |
| Aetna | Infliximab (0341) | listed, no stance (range 71045-71048) | Oct 5, 2026 | payer document |
| Aetna | Lung Cancer Screening (0380) | listed, no stance (range 71045-71048) | May 28, 2026 | payer document |
| Aetna | Mirikizumab-mrkz (Omvoh) (1048) | listed, no stance (range 71045-71048) | Jul 1, 2026 | payer document |
| Aetna | Risankizumab-rzaa (Skyrizi) (1009) | listed, no stance (range 71045-71048) | Jul 1, 2026 | payer document |
| Aetna | Secukinumab (Cosentyx) (0905) | listed, no stance (range 71045-71048) | Aug 11, 2026 | payer document |
| Aetna | Spesolimab-sbzo (Spevigo) (1013) | listed, no stance (range 71045-71048) | Apr 2, 2026 | payer document |
| Aetna | Tildrakizumab-asmn (Ilumya) (1012) | listed, no stance (range 71045-71048) | Jul 1, 2026 | payer document |
| Aetna | Tocilizumab (0799) | listed, no stance (range 71045-71048) | Jun 30, 2026 | payer document |
| Aetna | Tuberculosis Testing (0471) | listed, no stance (range 71045-71048) | Jul 23, 2026 | payer document |
| Aetna | Ustekinumab (0912) | listed, no stance (range 71045-71048) | Jul 1, 2026 | payer document |
| Aetna | Vedolizumab (Entyvio) (0885) | listed, no stance (range 71045-71048) | Jun 30, 2026 | payer document |
Prior authorization required or conditional in WV.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.